Advertisement

Rhofade Approved, Sun Leaves Acne Behind, Radiesse Turns 10
Rhofade Approved, Sun Leaves Acne Behind, Radiesse Turns 10

Rhofade Approved, Sun Leaves Acne Behind, Radiesse Turns 10

The FDA has approved Allergan's Rhofade (Oxymetazoline 1%) cream for the topical treatment of persistent facial erythema associated with rosacea in adults. New research from Olay in collaboration with personal genetics company 23andMe shows that taking care of the skin may be the key to looking up to 10 years younger. Research from Johnson & Johnson suggests that the combined use of sunscreen and a beach umbrella may be the best bet for skin protection. Sun Pharma is urging patients to “Leave Acne Behind with an awareness campaign for severe recalcitrant nodular acne (SRNA). With more than 6 million syringes sold worldwide, Radiesse from Merz Aesthetics marks its 10-year anniversary this year.

Advertisement